相关实验视频
Updated: May 20, 2025

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.0K
实施还是不实施? 关于判断个性化预测统计模型价值和风险的陷的评论
Linda Baumbach1,2, Walter Hötzendorfer3, Jan Baumbach1
1Center for Bioinformatics, Universität Hamburg, Hamburg, Germany.
Journal of medical Internet research
|May 19, 2025
概括
本评论指导在医疗保健中创建和使用个性化的预后模型,特别是对于像骨关节炎这样的疾病. 它提供了一个框架来衡量好处与危害,以便更好地做出患者护理决策.
科学领域:
- 医疗信息学 医疗信息学
- 临床决策支持 临床决策支持
- 医疗保健服务研究 医疗服务研究
背景情况:
- 预测模型在医学中至关重要,但其开发和实施的指南是不完整的.
- 关于何时创建或使用具有低于最佳性能模型的工具,存在不确定性.
研究的目的:
- 分析开发和实施基于预测模型的工具的优缺点.
- 为创建和实施个性化的预后工具提供结构化的决策框架.
- 解决使用来自性能有限的模型的工具的使用问题.
主要方法:
- 分析预测工具开发的优缺点.
- 关于实施基于调查的预测模型的理由的建议.
- 描述个性化预后模型与标准护理实施的场景和后果.
- 开发一个利风险得分公式和计算表.
主要成果:
- 实施的三个理由是:减轻预期偏见,推进个性化医疗,增强预测信息.
- 实施取决于上下文,并可能对患者造成危害.
- 一个结构化的方法,包括一个检查清单和计算表,有助于权衡好处和危害.
结论:
- 关于创建和实施个性化预后工具的决定必须考虑患者的益处,危害和背景.
- 一个结构化的利益-风险评分可以指导研究人员在决定实施或反对.
- 这项工作为改进医疗保健中预后工具开发的决策提供了基础.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
107
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
107
Cancer Survival Analysis
313
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
313
Comparing the Survival Analysis of Two or More Groups
103
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
103
Sensitivity, Specificity, and Predicted Value
153
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
153
Regression Toward the Mean
6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Kaplan-Meier Approach
66
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
66

